5 min read
|
Saved February 14, 2026
|
Copied!
Do you care about this?
This article outlines key metrics SaaS founders need to present during a Series A funding round. It highlights the importance of metrics like ARR, CAC, and NRR, explaining how they demonstrate business health and growth potential to investors. Understanding these numbers can significantly impact fundraising success.
If you do, here's more
SaaS metrics play a vital role in securing Series A funding. They reflect a company's health, scalability, and potential for valuation. Key metrics include Annual Recurring Revenue (ARR), which investors typically expect to be between $1.5 million and $3 million for a solid Series A raise. Monthly Recurring Revenue (MRR) is also crucial, as it helps analyze retention and forecast future revenue. Investors look for consistent MRR growth with minimal volatility, which is essential for assessing long-term viability.
Year-over-Year (YoY) growth indicates how quickly a company scales. Investors generally expect early-stage SaaS companies to achieve 2โ3x growth. High gross margins, ideally 70% or more, suggest a scalable business model, while low margins can raise concerns. Customer Acquisition Cost (CAC) and the CAC Payback Period are important for understanding how efficiently a company can grow. A shorter payback period allows for faster capital recovery, making the business more attractive to investors.
Lifetime Value (LTV) is another critical metric. A favorable LTV/CAC ratio of over 3x signals that a company can spend more on acquiring customers while still being profitable. Net Revenue Retention (NRR) above 100% is a strong indicator of customer satisfaction and product expansion potential, while Gross Revenue Retention (GRR) measures how well a company retains existing customers. Investors pay close attention to these metrics, as they can significantly impact valuation and growth prospects. Understanding and effectively communicating these figures can give founders a substantial advantage in fundraising efforts.
Questions about this article
No questions yet.